Posterior curves for the age-stratified seroprevalence (Figure 1A) exhibited a decreasing trend from ages 14 to 20 years but an upward trend from 26 to 30 years.
← all excerpts
P-1334. Assessment of Immunity Gaps and Determination of Optimal Age for Measles-Containing Vaccine Booster Dose in Measles-Endemic Country
1
—
—